If approved, AVT05 will be the first golimumab biosimilar in the U.S
Actividad antioxidante y antiinflamatoria: El GHK-Cu es un potente modulador del estrs oxidativo
A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy
According to FDA prescribing information, injection site reactions occur in approximately 2-10% of patients, varying by specific product
EatingDisorderHope.com, a website owned and operated by Hopeful Media, LLC, a wholly-owned subsidiary of Within Health Group, Inc., provides information intended for general consumer understanding and education and not as a substitute for medical or psychological advice, diagnosis, or treatment
10.21037/tcr-20-3018 214 YutaK.YukiS.SeiyaI.MinoruS.MasahitoT.ChiakiI.et al (2013)